Czechia – Pharmaceutical products – Medicinal product of ATC group L04AC18 with the active substance RISANKIZUMAB
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of the performance of the public contract is the provision of continuous supplies of medicinal products of the ATC group L04AC18 with the active ingredient RISANKIZUMAB for a period of 4 years.